Hormonal treatment increases the response of the reward system at the menopause transition: A counterbalanced randomized placebo-controlled fMRI study

Psychoneuroendocrinology

Volumn 50, Issue , 2014, Pages 167-180

  Thomas, Julie ^a   Météreau, Elise ^a   Déchaud, Henri ^a   Pugeat, Michel ^a   Dreher, Jean Claude ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

Critical time window hypothesis; Estradiol; Gonadal steroid hormones; Hormone therapy; Menopause; Reward processing

Indexed keywords

ESTRADIOL; FOLLITROPIN; GESTAGEN; PROGESTERONE;

ADULT; ANTICIPATION; ARTICLE; BEHAVIOR; BLOOD SAMPLING; BOLD SIGNAL; BRAIN FUNCTION; BRAIN REGION; CLIMACTERIUM; COGNITION; CONTROLLED STUDY; CORPUS STRIATUM; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ESTRADIOL BLOOD LEVEL; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HEDONIC BEHAVIOR; HORMONAL THERAPY; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; MENOPAUSE; MENSTRUAL CYCLE; MESENCEPHALON; MOTIVATION; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NORMAL HUMAN; OCCIPITAL GYRUS; POSTERIOR CINGULATE; PUTAMEN; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RESPONSE TIME; REWARD; SUPERIOR FRONTAL GYRUS; TASK PERFORMANCE; VENTROMEDIAL PREFRONTAL CORTEX; VISUAL CORTEX; WOMEN'S HEALTH QUESTIONNAIRE; BLOOD; BRAIN; DRUG EFFECTS; FUNCTIONAL NEUROIMAGING; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; REACTION TIME;

BRAIN; COGNITION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ESTRADIOL; FEMALE; FUNCTIONAL NEUROIMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; MENOPAUSE; MIDDLE AGED; PROGESTERONE; REACTION TIME; REWARD;

EID: 84908404732     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2014.08.012     Document Type: Article

References (57)

1. Anderson G.L., Limacher M., Assaf A.R., Bassford T., Beresford S.A., Black H., Bonds D., Brunner R., Brzyski R., Caan B., Chlebowski R., Curb D., Gass M., Hays J., Heiss G., Hendrix S., Howard B.V., Hsia J., Hubbell A., Jackson R., Johnson K.C., Judd H., Kotchen J.M., Kuller L., LaCroix A.Z., Lane D., Langer R.D., Lasser N., Lewis C.E., Manson J., Margolis K., Ockene J., O'Sullivan M.J., Phillips L., Prentice R.L., Ritenbaugh C., Robbins J., Rossouw J.E., Sarto G., Stefanick M.L., Van Horn L., Wactawski-Wende J., Wallace R., Wassertheil-Smoller S. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004, 291(14):1701-1712. Women's Health Initiative Steering Committee.
2. Andreano J.M., Cahill L. Menstrual cycle modulation of medial temporal activity evoked by negative emotion. NeuroImage 2010, 53(4):1286-1293.
3. Alonso-Alonso M., Ziemke F., Magkos F., Barrios F.A., Brinkoetter M., Boyd I., Rifkin-Graboi A., Yannakoulia M., Rojas R., Pascual-Leone A., Mantzoros C.S. Brain responses to food images during the early and late follicular phase of the menstrual cycle in healthy young women: relation to fasting and feeding. Am. J. Clin. Nutr. 2011, 94(2):377-384.
4. Bayer J., Bandurski P., Sommer T. Differential modulation of activity related to the anticipation of monetary gains and losses across the menstrual cycle. Eur. J. Neurosci. 2013, 38(10):3519-3526.
5. Becker J.B., Robinson T.E., Lorenz K.A. Sex differences and estrous cycle variations in amphetamine-elicited rotational behavior. Eur. J. Pharmacol. 1982, 80(1):65-72.
6. Becker J.B., Rudick C.N., Jenkins W.J. The role of dopamine in the nucleus accumbens and striatum during sexual behavior in the female rat. J. Neurosci. 2001, 21(9):3236-3241.
7. Becker J.B., Cha J.H. Estrous cycle-dependent variation in amphetamine-induced behaviors and striatal dopamine release assessed with microdialysis. Behav. Brain Res. 1989, 35(2):117-125.
8. Berent-Spillson A., Persad C.C., Love T., Tkaczyk A., Wang H., Reame N.K., Frey K.A., Zubieta J.K., Smith Y.R. Early menopausal hormone use influences brain regions used for visual working memory. Menopause (New York, NY) 2010, 17(4):692-699.
9. Berman K.F., Schmidt P.J., Rubinow D.R., Danaceau M.A., Van Horn J.D., Esposito G., Ostrem J.L., Weinberger D.R. Modulation of cognition-specific cortical activity by gonadal steroids: a positron-emission tomography study in women. Proc. Natl. Acad. Sci. U.S.A. 1997, 94(16):8836-8841.
10. Bethea C.L., Mirkes S.J., Shively C.A., Adams M.R. Steroid regulation of tryptophan hydroxylase protein in the dorsal raphe of macaques. Biol. Psychiatry 2000, 47:562-576.
11. Bos P.A., Panksepp J., Bluthé R.M., van Honk J. Acute effects of steroid hormones and neuropeptides on human social-emotional behavior: a review of single administration studies. Front. Neuroendocrinol. 2012, 33(1):17-35.
12. Brailoiu E., Dun S.L., Brailoiu G.C., Mizuo K., Sklar L.A., Oprea T.I., Prossnitz E., Dun N.J. Distribution and characterization of estrogen receptor G protein-coupled receptor 30 in the rat central nervous system. J. Endocrinol. 2007, 193:311-321.
13. Burger H.G., Dudley E.C., Hopper J.L., Groome N., Guthrie J.R., Green A., Dennerstein L. Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women. J. Clin. Endocrinol. Metab. 1999, 84(11):4025-4030.
14. Castner S.A., Goldman-Rakic P.S. Enhancement of working memory in aged monkeys by a sensitizing regimen of dopamine D1 receptor stimulation. J. Neurosci. 2004, 24(6):1446-1450.
15. Daniel J.M. Estrogens, estrogen receptors, and female cognitive aging: the impact of timing. Horm. Behav. 2013, 63(2):231-237.
16. Diekhof E.K., Kaps L., Falkai P., Gruber O. The role of the human ventral striatum and the medial orbitofrontal cortex in the representation of reward magnitude-an activation likelihood estimation meta-analysis of neuroimaging studies of passive reward expectancy and outcome processing. Neuropsychologia 2012, 50(7):1252-1266.
17. Dreher J.C., Kohn P., Berman K.F. Neural coding of distinct statistical properties of reward information in humans. Cerebral Cortex 2006, 16(4):561-573.
18. Dreher J.C., Schmidt P., Kohn P., Furman D., Rubinow D.R., Berman K.F. Menstrual cycle phase modulates reward-related neural function in women. Proc. Natl. Acad. Sci. U.S.A. 2007, 104(7):2465-2470.
19. Dreher J.C., Meyer-Lindenberg A., Kohn P., Berman K.F. Age-related changes in midbrain dopaminergic regulation of the human reward system. Proc. Natl. Acad. Sci. U.S.A. 2008, 105(39):15106-15111.
20. Dreher J.C., Kohn P., Kolachana B., Weinberger D.R., Berman K.F. Variation in dopamine genes influences responsivity of the human reward system. Proc. Natl. Acad. Sci. U.S.A. 2009, 106(2):617-622.
21. Eppinger B., Schuck N.W., Nystrom L.E., Cohen J.D. Reduced striatal responses to reward prediction errors in older compared with younger adults. J. Neurosci. 2013, 33(24):9905-9912.
22. Espeland M.A., Shumaker S.A., Leng I., Manson J.E., Brown C.M., LeBlanc E.S., Vaughan L., Robinson J., Rapp S.R., Goveas J.S., Wactawski-Wende J., Stefanick M.L., Li W., Resnick S.M. Long-term effects on cognitive function of postmenopausal hormone therapy prescribed to women aged 50 to 55 years. JAMA Intern. Med. 2013, 173(15):1429-1436. WHIMSY Study Group.
23. Goldstein J.M., Jerram M., Poldrack R., Ahern T., Kennedy D.N., Seidman L.J., Makris N. Hormonal cycle modulates arousal circuitry in women using functional magnetic resonance imaging. J. Neurosci. 2005, 25(40):9309-9316.
24. Hao J., Rapp P.R., Leffler A.E., Leffler S.R., Janssen W.G., Lou W., Lou W., McKay H., Roberts J.A., Wearne S.L., Hof P.R., Morrison J.H. Estrogen alters spine number and morphology in prefrontal cortex of aged female rhesus monkeys. J. Neurosci. 2006, 26(9):2571-2578.
25. Henderson V.W., Benke K.S., Green R.C., Cupples L.A., Farrer L.A. Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age. J. Neurol. Neurosurg. Psychiatry 2005, 76(1):103-105.
26. Henderson J.A., Bethea C.L. Differential effects of ovarian steroids and raloxifene on serotonin 1A and 2C receptor protein expression in macaques. Endocrine 2008, 33:285-293.
27. Jackson L.R., Robinson T.E., Becker J.B. Sex differences and hormonal influences on acquisition of cocaine self-administration in rats. Neuropsychopharmacology 2006, 31(1):129-138.
28. Kugaya A., Epperson C.N., Zoghbi S., van Dyck C.H., Hou Y., Fujita M., Staley J.K., Garg P.K., Seibyl J.P., Innis R.B. Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women. Am. J. Psychiatry 2003, 160:1522-1524.
29. Laflamme N., Nappi R.E., Drolet G., Labrie C., Rivest S. Expression and neuropeptidergic characterization of estrogen receptors (ERa and ERb) throughout the rat brain: anatomical evidence of distinct roles of each subtype. J. Neurobiol. 1998, 36:357-378.
30. Maki P.M., Gast M.J., Vieweg A.J., Burriss S.W., Yaffe K. Hormone therapy in menopausal women with cognitive complaints: a randomized, double-blind trial. Neurology 2007, 69(13):1322-1330.
31. McEwen B. Estrogen actions throughout the brain. Recent Prog. Horm. Res. 2002, 57:357-384.
32. Moses-Kolko E.L., Berga S.L., Greer P.J., Smith G., Cidis Meltzer C., Drevets W.C. Widespread increases of cortical serotonin type 2A receptor availability after hormone therapy in euthymic postmenopausal women. Fertil. Steril. 2003, 80:554-559.
33. Ossewaarde L., van Wingen G.A., Kooijman S.C., Bäckström T., Fernández G., Hermans E.J. Changes in functioning of mesolimbic incentive processing circuits during the premenstrual phase. Soc. Cogn. Affect. Neurosci. 2011, 6(5):612-620.
34. Pecins-Thompson M., Bethea C.L. Ovarian steroid regulation of serotonin-1A autoreceptor messenger RNA expression in the dorsal raphe of rhesus macaques. Neuroscience 1999, 89:267-277.
35. Popat R.A., Van Den Eeden S.K., Tanner C.M., McGuire V., Bernstein A.L., Bloch D.A., Leimpeter A., Nelson L.M. Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease. Neurology 2005, 65(3):383-390.
36. Protopopescu X., Pan H., Altemus M., Tuescher O., Polanecsky M., McEwen B., Silbersweig D., Stern E. Orbitofrontal cortex activity related to emotional processing changes across the menstrual cycle. Proc. Natl. Acad. Sci. U.S.A. 2005, 102(44):16060-16065.
37. Reddy D.S. Neurosteroids: endogenous role in the human brain and therapeutic potentials. Prog. Brain Res. 2010, 186:113-137.
38. Resnick S.M., Maki P.M., Rapp S.R., Espeland M.A., Brunner R., Coker L.H., Granek I.A., Hogan P., Ockene J.K., Shumaker S.A. Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J. Clin. Endocrinol. Metab. 2006, 91(5):1802-1810. Women's Health Initiative Study of Cognitive Aging Investigators.
39. Rinaldi S., Déchaud H., Toniolo P., Kaaks R. Reliability and validity of direct radioimmunoassays for measurement of postmenopausal serum androgens and estrogens. IARC Sci. Publ. 2002, 156:323-325.
40. Rinaldi S., Geay A., Déchaud H., Biessy C., Zeleniuch-Jacquotte A., Akhmedkhanov A., Shore R.E., Riboli E., Toniolo P., Kaaks R. Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations. Cancer Epidemiol. Biomarkers Prevent. 2002, 11(10 Pt 1):1065-1071.
41. Rocca W.A., Grossardt B.R., Shuster L.T. Oophorectomy, menopause, estrogen treatment, and cognitive aging: clinical evidence for a window of opportunity. Brain Res. 2011, 1379:188-198.
42. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., Jackson R.D., Beresford S.A., Howard B.V., Johnson K.C., Kotchen J.M., Ockene J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002, 288(3):321-333. Writing Group for the Women's Health Initiative Investigators.
43. Sanchez R.L., Reddy A.P., Centeno M.L., Henderson J.A., Bethea C.L. A second tryptophan hydroxylase isoform, TPH-2 mRNA, is increased by ovarian steroids in the raphe region of macaques. Brain Res. Mol. Brain Res. 2005, 135:194-203.
44. Saunders-Pullman R., Gordon-Elliott J., Parides M., Fahn S., Saunders H.R., Bressman S. The effect of estrogen replacement on early Parkinson's disease. Neurology 1999, 52(7):1417-1421.
45. Schott B.H., Minuzzi L., Krebs R.M., Elmenhorst D., Lang M., Winz O.H., Seidenbecher C.I., Coenen H.H., Heinze H.J., Zilles K., Düzel E., Bauer A. Mesolimbic functional magnetic resonance imaging activations during reward anticipation correlate with reward-related ventral striatal dopamine release. J. Neurosci. 2008, 28(52):14311-14319.
46. Sescousse G., Redoute J., Dreher J.C. The architecture of reward value coding in the human orbitofrontal cortex. J. Neurosci. 2010, 30(39):13095-13104.
47. Sescousse G., Caldù X., Segura B., Dreher J.C. Common and specific neural structures processing primary and secondary rewards: a quantitative voxel-based meta-analysis. Neurosci. Biobehav. Rev. 2013, 37(4):681-696.
48. Shafir T., Love T., Berent-Spillson A., Persad C.C., Wang H., Reame N.K., Frey K.A., Zubieta J.K., Smith Y.R. Postmenopausal hormone use impact on emotion processing circuitry. Behav. Brain Res. 2012, 226(1):147-153.
49. Sherwin B.B. Estrogen and memory in women: how can we reconcile the findings?. Horm. Behav. 2005, 47(3):371-375.
50. Sherwin B.B. Estrogen and cognitive functioning in women: lessons we have learned. Behav. Neurosci. 2012, 126(1):123-127.
51. Shumaker S.A., Legault C., Rapp S.R., Thal L., Wallace R.B., Ockene J.K., Hendrix S.L., Jones B.N., Assaf A.R., Jackson R.D., Kotchen J.M., Wassertheil-Smoller S., Wactawski-Wende J. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003, 289(20):2651-2662. WHIMS Investigators.
52. Stavarache M., Pfaff D., Schober J. Hormone effects on specific motivational states and underlying CNS arousal. Handbook of Reward and Decision Making 2009, Academic Press, Oxford. J.C. Dreher, L. Tremblay (Eds.).
53. Steiner M., Dunn E., Born L. Hormones and mood: from menarche to menopause and beyond. J. Affect. Disord. 2003, 74(1):67-83.
54. van Wingen G.A., van Broekhoven F., Verkes R.J., Petersson K.M., Bäckström T., Buitelaar J.K., Fernández G. Progesterone selectively increases amygdala reactivity in women. Mol. Psychiatry 2008, 13(3):325-333.
55. Volkow N.D., Gur R.C., Wang G.J., Fowler J.S., Moberg P.J., Ding Y.S., Hitzemann R., Smith G., Logan J. Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. Am. J. Psychiatry 1998, 155(3):344-349.
56. Whitmer R.A., Quesenberry C.P., Zhou J., Yaffe K. Timing of hormone therapy and dementia: the critical window theory revisited. Ann. Neurol. 2011, 69(1):163-169.
57. Wong D.F., Broussolle E.P., Wand G., Villemagne V., Dannals R.F., Links J.M., Zacur H.A., Harris J., Naidu S., Braestrup C., et al. In vivo measurement of dopamine receptors in human brain by positron emission tomography. Age and sex differences. Ann. N.Y. Acad. Sci. 1988, 515:203-214.